Sort
130,381 grants matching “hiv”
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
$987,196Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2023 · AI
Mucosal immunity and rectal challenge
$987,026Joseph John Mattapallil · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2009 · DE
An Etonogestrel/Ethinyl Estradiol/QGriffithsin (ETG/EE/QGRFT) IVR to Prevent Pregnancy and HIV
$987,021Natalia Teleshova · Population Council · R01 · FY2022 · AI
Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood
$987,019Cass T Miller · Redbud Labs, Inc. · R42 · FY2023 · GM
Enhance Prevention in Couples (EPIC)
$987,000Wafaa M. El-Sadr · Columbia University Health Sciences · R01 · FY2009 · AI
Acceptable Multi-user Biodegradable Extended Release (AMBER) Implant System for HIV Prevention
$986,995Leah Johnson · Research Triangle Institute · R01 · FY2020 · AI
IND-Enabling Development of HIV Maturation Inhibitors Formulated for use as either Oral or Long-Acting Parenterally Administered Agents
$986,894Carl Wild · Dfh Pharma, Inc. · R44 · FY2025 · AI
Miami Dade County ASsessment of Phylogenetics to Improve Resource Equity: MD ASPIRE
$986,875Susan Little · University Of California, San Diego · R01 · FY2022 · MH
SOUTHERN CALIFORNIA AIDS MALIGNANCY NETWORK
$986,746University Of California Los Angeles · U01 · FY2000 · CA
San Diego Export: An University Community Partnership E*
$986,727University Of California San Diego · P60 · FY2005 · MD
Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines
$986,671Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2021 · AI
NNTC Data Coordinating Center
$986,664Howard S. Fox · University Of Nebraska Medical Center · U24 · FY2021 · MH
Multi-level Optimization of the Cervical Cancer Screening Process in Diverse Settings & Populations (METRICS)
$986,593Amy E Hughes · Ut Southwestern Medical Center · UM1 · FY2023 · CA
Therapy Against Recalcitrant C. albicans Infection
$986,559Thomas A Dahl · Arietis · R44 · FY2010 · AI
A human cytomegalovirus-based immunotherapy for HIV-1
$986,519Eric Bruening · Tomegavax, Inc. · R44 · FY2015 · AI
Emory/Georgia TB Research Advancement Center (TRAC)
$986,410Neel Rajnikant Gandhi · Emory University · P30 · FY2022 · AI
NIAID Preclinical Development Support - Production of Research Cell Lines
$986,406Thomas Vancott · Advanced Bioscience Laboratories, Inc. · N02 · FY2014 · AI
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
$986,355Dhiraj Kumar Singh · Texas Biomedical Research Institute · R01 · FY2024 · AI
Molecular profile of proviral reservoirs in HIV-infected drug users
$986,339Xu Yu · Massachusetts General Hospital · R33 · FY2022 · DA
A human cytomegalovirus-based immunotherapy for HIV-1
$986,188Eric Bruening · Tomegavax, Inc. · R44 · FY2016 · AI
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
$986,138Matthew S Freiberg · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · HL
HIV AND THE SEXUAL NETWORKS OF IDUS AND DRUG-USING MSM
$986,118University Of Illinois At Chicago · U01 · FY2004 · DA
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$986,103Loretta Emily Haddy · West Virginia State Dept Hlth/Human Rscs · U62 · FY2013 · PS
Commercial Readiness for SAMBA HIV-1 Whole Blood Semi-Quantitative Test for Resource Limited Settings
$986,095Helen H Lee · Diagnostics For The Real World, Ltd · SB1 · FY2018 · AI
Efficacy of CBT for Adherence and Depression in HIV Care Settings
$986,019Steven A Safren · Massachusetts General Hospital · R01 · FY2009 · MH